JPMORGAN CHASE & CO

Position in LUCD — Lucid Diagnostics Inc.

CIK 19617 NEW YORK, NY

Position in LUCD

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$67,169

+$3,175 QoQ

Shares Held

62,775

+12.8% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#44

of 114 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $14,248,837,970 across 100 Medical Devices names. LUCD ranks #74 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SYK	Stryker Corp	17,260,943	$5,434,435,284
2	MDT	Medtronic plc	27,784,471	$2,173,579,157
3	EW	Edwards Lifesciences Corp	22,783,175	$2,060,966,003
4	ABT	Abbott Laboratories	15,095,898	$1,369,801,775
5	BSX	Boston Scientific Corp	23,907,838	$1,020,386,517
6	GEHC	GE HealthCare Technologies Inc.	10,329,164	$661,169,779
7	PEN	Penumbra Inc	1,071,454	$338,311,597
8	DXCM	Dexcom Inc	3,325,095	$223,945,140

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$67,169	62,775	+12.8%	Shares	Defined	2026-08-12
2026-03-31	$63,994	55,648	+34.1%	Shares	Defined	2026-05-13
2025-12-31	$45,240	41,506	+15.0%	Shares	Defined	2026-02-11
2025-09-30	$36,458	36,098	+10.3%	Shares	Defined	2025-11-07
2025-06-30	$37,624	32,718	+71026.1%	Shares	Defined	2025-08-12
2025-03-31	$67	46	-6.1%	Shares	Defined	2025-05-12
2024-12-31	$39	49	-3.9%	Shares	Defined	2025-02-12
2024-09-30	$40	51	+2.0%	Shares	Defined	2024-12-26
2024-06-30	$40	50	+47.1%	Shares	Defined	2024-12-26
2024-03-31	$26	34	-27.7%	Shares	Defined	2024-12-26
2023-12-31	$66	47	+261.5%	Shares	Defined	2024-12-26
2023-09-30	$15	13	-97.7%	Shares	Defined	2023-11-14
2022-06-30	$1,279	566	-76.1%	Shares	Defined	2022-08-11
2022-03-31	$7,953	2,367	-46.2%	Shares	Defined	2022-05-11
2021-12-31	$23,611	4,397	—	Shares	Defined	2022-02-11
No filing history on record for this holder in this stock.